True cost of sickle cell disease: $1.5 billion in lost productivity per year Sickle cell disease causes $1.5 billion in lost wages and productivity each year in the U.S. alone, according to the recent peer-reviewed study, titled “Indirect Economic Burden of Sickle Cell Disease” and published in the journal Value…..
A 100% French nasal vaccine against COVID-19 yields positive pre-clinical results In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus. The vaccine candidate, developed…..
Endeavor BioMedicines gains rights to lead ULK1/2 inhibitor molecule Endeavor BioMedicines, a clinical-stage precision medicine company targeting the core drivers of multiple terminal diseases, including oncology and fibrosis, has concluded an exclusive licensing agreement with the Salk Institute, along with Sanford Burnham Prebys. Under the license agreement, the California-based company…..
TreeFrog Therapeutics secures $75M in Series B financing to advance a pipeline of stem cell-derived cell therapies TreeFrog Therapeutics, a privately held French-based biotech startup focused on developing safe and affordable stem cell-derived cell therapies for millions of patients, today announced the successful closing of a $75 million (€64M) Series…..
